These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31107279)

  • 1. Continuation of Newly Initiated Midodrine Therapy After Intensive Care and Hospital Discharge: A Single-Center Retrospective Study.
    Rizvi MS; Nei AM; Gajic O; Mara KC; Barreto EF
    Crit Care Med; 2019 Aug; 47(8):e648-e653. PubMed ID: 31107279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
    Anstey MH; Wibrow B; Thevathasan T; Roberts B; Chhangani K; Ng PY; Levine A; DiBiasio A; Sarge T; Eikermann M
    BMC Anesthesiol; 2017 Mar; 17(1):47. PubMed ID: 28327122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine for the weaning of vasopressor infusions.
    Poveromo LB; Michalets EL; Sutherland SE
    J Clin Pharm Ther; 2016 Jun; 41(3):260-5. PubMed ID: 26945564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Use of Midodrine in the ICU: A Single-Center Retrospective Case Series.
    Rizvi MS; Trivedi V; Nasim F; Lin E; Kashyap R; Andrijasevic N; Gajic O
    Crit Care Med; 2018 Jul; 46(7):e628-e633. PubMed ID: 29613861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions.
    Levine AR; Meyer MJ; Bittner EA; Berg S; Kalman R; Stanislaus AB; Ryan C; Ball SA; Eikermann M
    J Crit Care; 2013 Oct; 28(5):756-62. PubMed ID: 23845791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.
    Santer P; Anstey MH; Patrocínio MD; Wibrow B; Teja B; Shay D; Shaefi S; Parsons CS; Houle TT; Eikermann M;
    Intensive Care Med; 2020 Oct; 46(10):1884-1893. PubMed ID: 32885276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Safety of Discharging Select Patients Directly Home From the Intensive Care Unit: A Multicenter Population-Based Cohort Study.
    Stelfox HT; Soo A; Niven DJ; Fiest KM; Wunsch H; Rowan KM; Bagshaw SM
    JAMA Intern Med; 2018 Oct; 178(10):1390-1399. PubMed ID: 30128550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Readmission to the Intensive Care Unit: Incidence, Risk Factors, Resource Use, and Outcomes. A Retrospective Cohort Study.
    Ponzoni CR; Corrêa TD; Filho RR; Serpa Neto A; Assunção MSC; Pardini A; Schettino GPP
    Ann Am Thorac Soc; 2017 Aug; 14(8):1312-1319. PubMed ID: 28530118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility, Utility, and Safety of Midodrine During Recovery Phase From Septic Shock.
    Whitson MR; Mo E; Nabi T; Healy L; Koenig S; Narasimhan M; Mayo PH
    Chest; 2016 Jun; 149(6):1380-3. PubMed ID: 26953217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year outcomes for Medicare beneficiaries who survive intensive care.
    Wunsch H; Guerra C; Barnato AE; Angus DC; Li G; Linde-Zwirble WT
    JAMA; 2010 Mar; 303(9):849-56. PubMed ID: 20197531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential risks in using midodrine for persistent hypotension after cardiac surgery: a comparative cohort study.
    Tremblay JA; Laramée P; Lamarche Y; Denault A; Beaubien-Souligny W; Frenette AJ; Kontar L; Serri K; Charbonney E
    Ann Intensive Care; 2020 Sep; 10(1):121. PubMed ID: 32926256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality after hospital discharge in ICU patients.
    Brinkman S; de Jonge E; Abu-Hanna A; Arbous MS; de Lange DW; de Keizer NF
    Crit Care Med; 2013 May; 41(5):1229-36. PubMed ID: 23591209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital mortality, length of stay, and preventable complications among critically ill patients before and after tele-ICU reengineering of critical care processes.
    Lilly CM; Cody S; Zhao H; Landry K; Baker SP; McIlwaine J; Chandler MW; Irwin RS;
    JAMA; 2011 Jun; 305(21):2175-83. PubMed ID: 21576622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU.
    Gregory J; Greenberg J; Basu S
    Pediatr Crit Care Med; 2019 Apr; 20(4):e185-e190. PubMed ID: 30520798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral midodrine is effective for the treatment of hypotension associated with carotid artery stenting.
    Sharma S; Lardizabal JA; Bhambi B
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):94-7. PubMed ID: 18495904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of the premature discharge on hospital mortality after a stay in an intensive care unit].
    Rodríguez-Carvajal M; Mora D; Doblas A; García M; Domínguez P; Tristancho A; Herrera M
    Med Intensiva; 2011 Apr; 35(3):143-9. PubMed ID: 21419522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study.
    Gayat E; Cariou A; Deye N; Vieillard-Baron A; Jaber S; Damoisel C; Lu Q; Monnet X; Rennuit I; Azoulay E; Léone M; Oueslati H; Guidet B; Friedman D; Tesnière A; Sonneville R; Montravers P; Pili-Floury S; Lefrant JY; Duranteau J; Laterre PF; Brechot N; Chevreul K; Michel M; Cholley B; Legrand M; Launay JM; Vicaut E; Singer M; Resche-Rigon M; Mebazaa A
    Crit Care; 2018 Jan; 22(1):8. PubMed ID: 29347987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intensive care unit discharge time on patient outcome.
    Priestap FA; Martin CM
    Crit Care Med; 2006 Dec; 34(12):2946-51. PubMed ID: 17075364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIBERATE: a study protocol for midodrine for the early liberation from vasopressor support in the intensive care unit (LIBERATE): protocol for a randomized controlled trial.
    Opgenorth D; Baig N; Fiest K; Karvellas C; Kutsogiannis J; Lau V; Macintyre E; Senaratne J; Slemko J; Sligl W; Wang X; Bagshaw SM; Rewa OG
    Trials; 2022 Mar; 23(1):194. PubMed ID: 35246227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Intensive Care Unit Discharge Delays on Patient Outcomes: A Retrospective Cohort Study.
    Bose S; Johnson AEW; Moskowitz A; Celi LA; Raffa JD
    J Intensive Care Med; 2019; 34(11-12):924-929. PubMed ID: 30270722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.